Survival of medically treated beta Thalassaemia patients in Sri Lanka (2000 – 2017)
International Journal of Development Research
Survival of medically treated beta Thalassaemia patients in Sri Lanka (2000 – 2017)
Received 28th January, 2018, Received in revised form, 10th February, 2018, Accepted 19th March, 2018, Published online 30th April, 2018
Copyright © 2018, Anulawathie Menike and Wijesinghe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Beta thalassaemia is what is called an inherited disease due to abnormal hemoglobin production. It’s not an infectious disease. Near to 3,500 patients with beta thalassaemia lives in Sri Lanka. The survival measures and factors that affect to survival thalassaemia patients in Sri Lanka is unclear. Therefore, this study was mainly performed to determine the statistical analyze on survival of the beta thalassaemia patients in Sri Lanka. Relevant data were collected from Hemals thalassaemia care unit in Ragama hospital during the time period between 2000 and 2017. To succeed the objectives new births, death rates, survival rates were measured. Analyzed data showed new affected births were decreasing after starting national prevention program in 2007. No significant difference occurred in survival time by gender. When considering the diagnosis types beta thalassaemia major patients had the least survival time compared to others. By considering these results it could be concluding that the survival of beta thalassaemia patients in Sri Lanka is still need of great attention.
